Eucrisa

DRUG2 trials

Sponsors

Wake Forest University Health Sciences, Applied Biology, Inc.

Conditions

Atopic DermatitisMild to Moderate Atopic Dermatitis

Phase 1

Eucrisa for Atopic Dermatitis

CompletedNCT03250663

Wake Forest University Health SciencesMild to Moderate Atopic Dermatitis

Start: 2017-10-01End: 2022-07-27Updated: 2025-07-02

Phase 3

Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

WithdrawnNCT05016284

Applied Biology, Inc.Atopic Dermatitis

Start: 2022-11-24End: 2022-12-15Updated: 2022-12-19

Related Papers

Measuring and Improving Adherence to Crisaborole 2% Ointment in Patients With Atopic Dermatitis

Journal of Drugs in Dermatology2022-09-016 citations